Skip to main content
Premium Trial:

Request an Annual Quote

Not Just Taking on Gene Patents, But Tackling the USPTO Too

Larry Smith at the Bulletproof Blog has a Q&A with Chris Hansen, an attorney working on the Association for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al. case challenging gene patents. Hansen, who says he expects this case to be appealed "all the way to the Supreme Court," adds that the impact of overturning the patents would open the floodgates for other gene patents to be challenged as well. "Practically, however, the impact would be even more decisive. A favorable decision upheld throughout the appeals process would effectively establish a guiding principle that no one should be able to patent a part of the human body," he says.

Over at Patent Baristas, Stephen Albainy-Jenei adds, "More significant than one crazy suit regarding gene patents is the fact that the suit names the US Patent & Trademark Office as a defendant, and then asks the court to issue an affirmative injunction requiring the USPTO to revoke the patents in suit. ... If this case stands, then anyone could sue the USPTO — and not the actual patent owner — in any Federal District Court, in any jurisdiction, to challenge any patent. It would seem that such a suit could now go forward without participation of the patent holder."

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.